Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Effects of the Communities that Heal (CTH) intervention on perceived opioid-related community stigma in the HEALing Communities Study: results of a multi-site, community-level, cluster-randomized trial

  • Alissa Davis
  • , Hannah K. Knudsen
  • , Daniel M. Walker
  • , Deborah Chassler
  • , Karsten Lunze
  • , Philip M. Westgate
  • , Emmanuel Oga
  • , Sandra Rodriguez
  • , Sylvia Tan
  • , Ja Nae Holloway
  • , Sharon L. Walsh
  • , Carrie B. Oser
  • , R. Craig Lefebvre
  • , Laura C. Fanucchi
  • , La Shawn Glasgow
  • , Ann Scheck McAlearney
  • , Hilary L. Surratt
  • , Michael W. Konstan
  • , Terry T.K. Huang
  • , Patricia LeBaron
  • Julie Nakayima, Michael D. Stein, Maria Rudorf, Monica Nouvong, Elizabeth N. Kinnard, Nabila El-Bassel, Jess Tilley, Aaron Macoubray, Caroline Savitzky, Amy Farmer, Donna Beers, Pamela Salsberry, Timothy R. Huerta

Producción científica: Articlerevisión exhaustiva

22 Citas (Scopus)

Resumen

Background: Community stigma against people with opioid use disorder (OUD) and intervention stigma (e.g., toward naloxone) exacerbate the opioid overdose crisis. We examined the effects of the Communities that HEAL (CTH) intervention on perceived opioid-related community stigma by stakeholders in the HEALing Communities Study (HCS). Methods: We collected three surveys from community coalition members in 66 communities across four states participating in HCS. Communities were randomized into Intervention (Wave 1) or Wait-list Control (Wave 2) arms. We conducted multilevel linear mixed models to compare changes in primary outcomes of community stigma toward people treated for OUD, naloxone, and medication for opioid use disorder (MOUD) by arm from time 1 (before the start of the intervention) to time 3 (end of the intervention period in the Intervention arm). Findings: Intervention stakeholders reported a larger decrease in perceived community stigma toward people treated for OUD (adjusted mean change (AMC) −3.20 [95% C.I. −4.43, −1.98]) and toward MOUD (AMC −0.33 [95% C.I. −0.56, −0.09]) than stakeholders in Wait-list Control communities (AMC −0.18 [95% C.I. −1.38, 1.02], p = 0.0007 and AMC 0.11 [95% C.I. −0.09, 0.31], p = 0.0066). The relationship between intervention status and change in stigma toward MOUD was moderated by rural-urban status (urban AMC −0.59 [95% CI, −0.87, −0.32], rural AMC not sig.) and state. The difference in stigma toward naloxone between Intervention and Wait-list Control stakeholders was not statistically significant (p = 0.18). Interpretation: The CTH intervention decreased stakeholder perceptions of community stigma toward people treated for OUD and stigma toward MOUD. Implementing the CTH intervention in other communities could decrease OUD stigma across diverse settings nationally. Funding: US National Institute on Drug Abuse.

Idioma originalEnglish
Número de artículo100710
PublicaciónThe Lancet Regional Health - Americas
Volumen32
DOI
EstadoPublished - abr 2024

Nota bibliográfica

Publisher Copyright:
© 2024 The Author(s)

Financiación

This research was supported by the National Institutes of Health and the Substance Abuse and Mental Health Services Administration through the NIH HEAL (Helping to End Addiction Long-Term℠) Initiative under award numbers UM1DA049394, UM1DA049406, UM1DA049412, UM1DA049415, UM1DA049417 (ClinicalTrials.gov Identifier: NCT04111939). This study protocol (Pro00038088) was approved by Advarra Inc. , the HEALing Communities Study single Institutional Review Board . AD is supported by a career development award from the National Institute on Drug Abuse (K01DA044853). TTKH is additionally supported by a grant from the Centers for Disease Control and Prevention (U48DP006396).

FinanciadoresNúmero del financiador
Substance Abuse and Mental Health Services Administration
National Institutes of Health (NIH)UM1DA049412, UM1DA049394, UM1DA049415, NCT04111939, UM1DA049417, UM1DA049406
Author National Institute on Drug Abuse DA031791 Mark J Ferris National Institute on Drug Abuse DA006634 Mark J Ferris National Institute on Alcohol Abuse and Alcoholism AA026117 Mark J Ferris National Institute on Alcohol Abuse and Alcoholism AA028162 Elizabeth G Pitts National Institute of General Medical Sciences GM102773 Elizabeth G Pitts Peter McManus Charitable Trust Mark J Ferris National Institute on Drug AbuseK01DA044853
Centers for Disease Control and PreventionU48DP006396

    ODS de las Naciones Unidas

    Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

    1. Good health and well being
      Good health and well being

    ASJC Scopus subject areas

    • Internal Medicine
    • Health Policy
    • Public Health, Environmental and Occupational Health

    Huella

    Profundice en los temas de investigación de 'Effects of the Communities that Heal (CTH) intervention on perceived opioid-related community stigma in the HEALing Communities Study: results of a multi-site, community-level, cluster-randomized trial'. En conjunto forman una huella única.

    Citar esto